Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT00025467 · COMPLETED

Trial details

NCT number: NCT00025467
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Adenoacanthoma Endometrial Adenocarcinoma Endometrial Adenosquamous Cell Carcinoma Endometrial Clear Cell Carcinoma Endometrial Papillary Serous Carcinoma Recurrent Endometrial Carcinoma

Start date: 2001-09-01
Primary completion: 2007-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.